Company intelligence / Profile preview

Softcaps

Ownership: Private
Development stage: Commercial

Overview

Softcaps is an independent team of pharmaceutical scientists with over 30 years’ experience in soft capsule development. They provide expert consulting and project management across the full lifecycle of softgel product development—including formulation design, CMC documentation preparation for regulatory filings (IND/IMPD), partner selection, risk assessment, and troubleshooting. Their portfolio includes more than 50 successful softgel capsule projects brought to market in the EU and USA[1][3].

Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Extensive network/database of CDMOs/CMOs and analytical partners for soft gel capsule manufacturing

Beyond the preview

Go deeper on Softcaps.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Softcaps.

Explore the full profile